Application no. and date | 13786884.0 (espacenet) (Federated) (European Patent Register), 20131030 | Patent/reg. no. and date | DK/EP 2914627, 20210407 | Publication date | 20150909 | Priority no. and date | US 201261720289 P, 20121030 | EP pub. no. and date |
EP 2914627 20150909 | Effective date | | Applicant/owner | Apexigen, Inc., 75 Shoreway Road, Suite C
San Carlos, CA 94070, US | Applicant ref. no. | P3011DKEP | Inventor | YU, Guo-Liang, 1025 Tournament Drive
Hillsborough, California 94010, US, ZHANG, Yongke, 119 Stockton Place
Palo Alto, California 94303, US, ZHU, Weimin, 1216 Toyon Drive
Millbrae CA 94030, US | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | Opponent | | IPC Class | A61K 39/00 (2006.01) , C07K 16/28 (2006.01) | Title | ANTI-CD40-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE | Int. application no. | US2013067583 | Int. publication no. | WO2014070934 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|